Breaking Biotech

044 - Marker Therapeutics DISAPPOINTS in pancreatic cancer


Listen Later

Hi all, today I talk about the #MRKR interim update of their MultiTAA treatment in pancreatic cancer. I go through the data in all 3 arms and analyze whether or not they see an actual effect of their unique therapy. www.breakingbiotech.com this is not investment advice breaking biotech #biotech Support Breaking Biotech by donating to the tip jar: https://tips.pinecast.com/jar/breaking-biotech
...more
View all episodesView all episodes
Download on the App Store

Breaking BiotechBy Matthew Lepoire

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

24 ratings